Trinity Biotech has bought the Washington, US-based diagnostics manufacturer Bartels for $9.3 million (€10.41 million). Founded in 1978, Bartels is a world leader in the development and manufacture of diagnostic products for the identification of infectious agents which are cell dependent.
Trinity Biotech buys Bartels
Trinity Biotech has bought the Washington, US-based diagnostics manufacturer Bartels for $9.3 million (€10.41 million)
From maternity leave to remote working: Submit your work-related questions here
Listen to Inside Business podcast for a look at business and economics from an Irish perspective
Sign up to the Business Today newsletter for the latest new and commentary in your inbox
Presbyterian Church’s failure to protect most vulnerable leaves it in a state of crisis
Kellie Harrington crowned Irish champion after comeback from retirement
Connacht put 11 tries past Montauban on way to Challenge Cup knockout stages
European Film Awards: Sentimental Value wins big at politically-charged ceremony
Fine margins mount to end Munster’s Champions Cup campaign against Castres
Business Today
Get the latest business news and commentary from our expert business team in your inbox every weekday morning